Biopharmaceutical Industry in Japan Market Research & Statistics

24/7 Customer Support

Talk to Sam

+1 718 473 0872

All regions

23 reports

Download Unlimited Documents from Trusted Public Sources

Protein Overview in Japan

  • December 2014
    24 pages
  • Protein  

    Glucose  

  • Japan  

View report >

Biopharmaceutical Industry in Japan

  • September 2014
    3 pages
  • Influenza  

  • Japan  

View report >

Antibody Market in Japan

  • January 2014
    10 pages
  • Antibody  

  • Japan  

View report >

Biopharmaceutical Industry in Asia

  • January 2012
    14 pages
  • Biopharmaceutic  

    Enzyme Product  

    Enzyme  

  • India  

    Japan  

    Asia  

View report >

Protein Industry in the US and Japan

  • January 2012
    8 pages
  • Protein  

  • United States  

    Japan  

View report >

Antibody market trends in Japan

  • August 2011
    6 pages
  • Antibody  

View report >

Biopharmaceutical market shares in Japan and France

  • June 2011
    3 pages
  • Biopharmaceutic  

  • Japan  

    France  

View report >

Protein supply in Japan

  • January 2011
    6 pages
  • Protein  

  • Japan  

View report >

Protein Supply in Japan

  • January 2010
    3 pages
  • Protein  

  • Japan  

View report >

Protein Industry in Japan

  • January 2010
    8 pages
  • Protein  

  • Japan  

    Asia  

View report >

Search in Biopharmaceutical Industry
Topics under Biopharmaceutical

Parent industry:  Biotechnology

Related industries: Biological Therapy, Biomaterial, Genetically Modified Organism, GMO, Genomics

30 reports

Purchase Reports From Reputable Market Research Publishers
(From $ 300 - $ 4 000)

New Phase of Mab biosimilar knocks the door  Biosimilar Oppurtunities In Japan

New Phase of Mab biosimilar knocks the door Biosimilar Oppurtunities In Japan

  • $ 4 000
  • Industry report
  • February 2015
  • by MP Advisors

The launch of Remicade biosimilar in Dec-2014 in the Japan pharma market demonstrated its changing regulatory environment; it is faster than U.S. in adapting to biosimilar use. After nine years of continuous ...

New Phase Of Mab Biosimilar Knocks The Door Biosimilar ...

January 2015 $ 4 000

Abnova Corporation (symbol:4133) Swot Analysis, Strateg ...

January 2015 $ 300

Amano Enzyme Inc. Swot Analysis, Strategy, Revenues And ...

November 2014 $ 300

Medy-tox Inc. (symbol:086900) Swot Analysis, Strategy, ...

November 2014 $ 300

Umn Pharma Inc. (4584) - Financial And Strategic Swot A ...

November 2014 $ 300

Biosimilars Business Review Q3 2014

September 2014 $ 1 114

Pea Protein Market By Type [isolates, Concentrates, And ...

September 2014 $ 4 650

Pharmasphere: Regulatory Frameworks And Product Pipelin ...

June 2014 $ 2 995

Sports Nutrition Market Overview In Japan

June 2014 $ 898

ReportLinker is an award-winning market research solution that finds, filters and organizes the latest industry data so you get all the market research you need - quickly, in one place.